New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines-Reference-Cited by-同舟云学术

New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

Published:2010-01-07 Issue:1 Volume:124 Page:101-110
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Colin Christelle,Salamone Stéphane,Grillier-Vuissoz Isabelle,Boisbrun Michel,Kuntz Sandra,Lecomte Julie,Chapleur Yves,Flament Stéphane

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-009-0700-y.pdf

Reference42 articles.

1. Sørlie T (2004) Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer 40(18):2667–2675

2. Early Breast Cancer Trialist’ Collaborative Group (EBCTC) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687–1717

3. Nahta R, Esteva FJ (2006) Herceptin: mechanisms of action and resistance. Cancer Lett 232(2):123–138

4. Burstein HJ, Demetri GD, Mueller E et al (2003) Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand TGZ as treatment for refractory breast cancer: a phase II study. Breast Cancer Res Treat 79:391–397

5. Yee LD, Williams N, Wen P et al (2007) Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum marker. Clin Cancer Res 13:246–252

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Drug Discovery By Structure-Based Repositioning Approach;Mini-Reviews in Medicinal Chemistry;2024-01

2. Claudin 1: An Emerging Target for Triple-Negative Breast Cancer;Interdisciplinary Cancer Research;2024

3. Photoisomerization of Arylidene Heterocycles: Toward the Formation of Fused Heterocyclic Quinolines;The Journal of Organic Chemistry;2022-07-08

4. AB186 Inhibits Migration of Triple-Negative Breast Cancer Cells and Interacts with α-Tubulin;International Journal of Molecular Sciences;2022-06-20

5. Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling;iScience;2022-06